Skip Navigation

OncoTheis Wins 2015 Lush Science Prize for In Vitro Cancer Modeling

OncoTheis has won the prestigious 2015 Lush Science Prize for its OncoCilAir™project.

OncoCilAir™ is a unique in vitro human lung-cancer modelthat recapitulates tumor growth in functional airway tissue. OncoCilAir™ allows testing drug efficacy and side-toxicity, drug resistance, and tumor recurrence.

OncoTheis is a Swiss biotech company dedicated to developing innovative bioengineered tissues and organoids for cancer research. The have produced a new generation of integrated 3D in vitro models that combine both healthy and cancerous tissues in order to accurately simulate in vivo situation. Such models are intended to increase the quality of preclinical research while reducing animal testing.

Since 2014, OncoTheis has received several prizes recognizing its involvement in the development of reliable in vitro alternatives to animal experimentation, including the Egon Naëf Foundation prize, the EthicScience award and now, the Lush Science Prize.

New ALTEX:1/2018

ALTEX cover 1/2018
 

Support ALTWEB, Make a Gift
Online Humane Science Course

MeetingS

 
Building a Better Epithelium: Breaking the Barrier to the Next Generation of Toxicity Testing
March 10, 2018
San Antonio, TX

SOT Satellite Meeting: Updates on Activities Related to 21st Century Toxicology and Related Efforts: Invited Presentations and Open Mic
March 15, 2018
San Antonio, TX

SAVE THE DATE!
Social Housing Workshop
June 4-5, 2018
Beltsville, MD
Email: kherrma1@jhu.edu

SAVE THE DATE!
2nd Pan-American Conference for Alternative Methods
August 23-24, 2018
Rio de Janeiro, Brazil 

Eurotox 2018
September 2-5, 2018
Brussels, Belgium

20th International Congress on In Vitro Toxicology (ESTIV2018)
October 15-18, 2018
Berlin
 

More Meetings...